Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30576
Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based Adjuvants

Authors: Nelly К. Akhmatova, Оlga V. Lebedinskaya, Ancha V. Baranova, Еlena А. Lebedinskaya, Ekaterina V. Sorokina, Elvin А. Akhmatov, Аnatoliy P. Godovalov, Stanislav G. Markushin

Abstract:

An influence of intranasal combined injection of live cold-adapted influenza vaccine with chitosan derivatives as adjuvants on the subpopulation structure of mononuclear leukocytes of mouse spleen which reflects the orientation of the immune response was studied. It is found that the inclusion of chitosan preparations promotes activation of cellular-level of immune response.

Keywords: chitosan, Immunophenotype, cold-adapted vaccine, intranasal injection

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1076860

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1398

References:


[1] N.K. Akhmatova, N.B. Egorova, E.A. Kurbatova, I.B. Semenova, O.M. Kuz'menko, R.V. Shcherbakov, S.G. Markushin, Iu.Z. Gendon, "Influence of chitosan on immunophenotype and functional activity of murine mononuclear leukocytes after immunization with inactivated influenza vaccine", Zh. Mikrobiol. Epidemiol. Immunobiol. Nov- Dec;(6), 2008, pp. 31-35.
[2] S.G. Markushin, Iu.Z. Gendon, G.G. Krivtsov, I.I. Akopova, A.S. Sukhno, A.D. Pereverzev, "Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant", Zh. Mikrobiol. Epidemiol. Immunobiol. Sep-Oct ;(5), 2010, pp. 29-34.
[3] A. Bacon, J. Makin, P.J. Sizer, I. Jabbal-Gill, M. Hinchcliffe, L. Illum, S. Chatfield, M. Roberts, "Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens", Infect. Immun., vol. 68, 2000, pp. 5764-5770.
[4] Y. Ghendon, S. Markushin, G. Krivtsov, I. Akopova, "Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines", Arch. Virol., vol. 153, 2008, pp. 831-837.
[5] Y. Ghendon, S. Markushin, Y. Vasiliev, I. Akopova, I. Koptiaeva, G. Krivtsov, O. Borisova, N. Ahmatova, E. Kurbatova, S. Mazurina, V. Gervazieva, "Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally", Journal of Medical Virology, vol. 81, 2009, pp. 494-506.
[6] R. Gupta, G. Siber, "Adjuvant for human vaccines -current status, problems and future prospects", Vaccine, vol. 13, 1995, pp. 1263-1276.
[7] L. Illum, "Nasal drug delivery - possibilities, problems and solutions", J. Control. Release, vol. 87, 2003, pp. 187-198.
[8] L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A.N. Fisher, S.S. Davis, "Chitosan as a novel nasal delivery system for vaccines", Adv. Drug. Deliv. Rev., vol. 51, 2001, pp. 81-96.
[9] I.M. van der Lubben, J.C. Verhoef, G. Borchard, H.E. Junginger, "Chitosan and its derivatives in mucosal drug and vaccine delivery", Europ. J. Pharm. Sci., vol. 14, 2001, pp. 201-207.
[10] I.M. van der Lubben, G. Kersten, M.M. Fretz, C. Beuvery, J. Coos Verhoef, H.E. Junginger, "Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice", Vaccine, vol. 21, 2003, pp. 1400-1408.
[11] S.A. Kopecky-Bromberg, K.A. Fraser, N. Pica, E. Carnero, T.M. Moran, R.W. Franck, M. Tsuji, P. Palese, "Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine", Vaccine, vol. 8;27(28), pp. 3766-3774.
[12] A.R. Rekstin, K. Lu, D. Kats, L.G..Rudenko "Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses", Vopr. Virusol. Mar- Apr; 51(2), 2006, pp. 27-30.